🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim to evaluate the efficacy and safety of luvometinib combined with anloti...
Status
Not Yet Recruiting
Location
Shanghai Chest Hospital
Start Date
2026-06
Trial ID
NCT07562581
Treatments Being Tested
This is an investigator-initiated, exploratory, multicenter, open-label, si...
Status
Not Yet Recruiting
Location
Xuanwu Hospital, Capital Medical University
Start Date
2026-07-31
Trial ID
NCT07708285
Treatments Being Tested
This is an adaptive platform-basket trial that aims to evaluate the safety ...
Status
Not Yet Recruiting
Location
Xuanwu Hospital, Capital Medical University
Start Date
2026-07-18
Trial ID
NCT07713745
Treatments Being Tested
Langerhans cell histiocytosis (LCH) is the most common type of histiocytic ...
Status
Recruiting
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2026-06-19
Trial ID
NCT07371182
Treatments Being Tested
This single-center, prospective, interventional phase 2 study evaluates a r...
Status
Not Yet Recruiting
Location
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-06-30
Trial ID
NCT07728201
Treatments Being Tested
An open-label, randomized, multi-center phase III clinical study: Aim to ev...
Status
Not Yet Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2025-06-30
Trial ID
NCT07004075
Treatments Being Tested
FCN-159 (Luvometinib Tablets), an orally available and highly potent select...
Status
Not Yet Recruiting
Location
Shanghai Ninth People's Hospital
Start Date
2025-06-12
Trial ID
NCT07024394
Treatments Being Tested
Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder...
Status
Recruiting
Location
West China Second Hospital, Sichuan University
Start Date
2026-02-13
Trial ID
NCT07431060
Treatments Being Tested